| Fund ID | 805-9591167302 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | Yes |
| Relies on exemption from registration | No |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 1% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 99% |
| Fund | Type | Gross assets |
|---|---|---|
| Q-Ventures Program II, L.P. | Private Equity | $588.3M |
| J Ventures Program, L.P | Private Equity | $515.9M |
| Keva Investments IV, L.P. | Private Equity | $451.1M |
Life Science Impact Program, L.P. reports $94.8 million in gross assets, among the top 43% of private funds by size.
Life Science Impact Program, L.P. is managed by Grove Street Advisors, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.